Dispensary Closures 2026: Why Cannabis Retailers Are Shutting Down

Executive Summary

Cannabis dispensaries across the United States are closing at an accelerating rate in 2026, driven by a convergence of oversupply, regulatory burden, and capital market collapse. Industry data through May 2026 indicates that approximately 15-18% of licensed retail locations have shuttered since January 2024, with the pace quickening in states that legalized adult-use sales between 2020 and 2023. The crisis stems from three compounding factors: wholesale cannabis prices that have fallen 60-75% since 2021 in mature markets like California and Colorado, continued federal prohibition under the Controlled Substances Act that blocks normal bankruptcy protection and maintains the punitive IRC Section 280E tax treatment, and the evaporation of cannabis-specific venture capital following the 2022-2023 market correction. Small operators face impossible unit economics while multi-state operators consolidate or retreat to profitable core markets. The closures represent a market correction after years of overexpansion, but they also expose structural flaws in state-by-state regulatory frameworks that created artificial scarcity through limited licenses while simultaneously failing to control supply once cultivation ramped up.

Why Dispensary Closures Matter

The wave of dispensary closures directly affects patient access, employment, tax revenue, and the viability of state-legal cannabis markets as policy experiments. For medical cannabis patients, particularly those in rural areas or states with limited retail infrastructure, each closure extends travel distances and reduces product selection. States like Ohio and Pennsylvania, which maintain medical-only programs with tightly controlled dispensary counts, see individual closures create access deserts spanning multiple counties. In Oklahoma, which issued licenses liberally and saw explosive growth through 2022, the subsequent contraction has left former patients without nearby options or forced them back to unregulated sources. The employment impact is substantial. The cannabis industry employed approximately 428,000 workers nationwide as of December 2023, according to industry analytics firm Headset. Dispensary closures in 2024-2026 have eliminated an estimated 35,000-50,000 retail positions, with cascading effects on cultivation, processing, and ancillary service providers. Unlike traditional retail, displaced cannabis workers cannot easily transfer skills to other sectors due to the industry's regulatory isolation and the federal prohibition that creates employment barriers for workers with cannabis industry experience. State and local governments face revenue shortfalls as closures reduce sales tax and excise tax collections. California projected $1.1 billion in cannabis tax revenue for fiscal year 2025-2026 but revised estimates downward by $180 million in March 2026 as closures accelerated. Michigan, Colorado, and Illinois have similarly adjusted revenue forecasts. Municipalities that approved dispensaries expecting ongoing tax streams now confront budget gaps, particularly in smaller jurisdictions where a single dispensary closure can represent 2-5% of total municipal revenue. The closures also represent a policy stress test. States designed regulatory frameworks assuming steady growth and stable markets. The current contraction reveals which policy choices—license caps, vertical integration requirements, residency mandates, local control provisions—create resilient markets versus fragile ones. The data emerging from 2024-2026 will shape the next generation of legalization efforts in states like Kansas, Kentucky, and North Carolina.

Background and History: The Path to Oversupply

The 2026 dispensary closure crisis is the culmination of a decade-long expansion cycle that ignored basic supply-demand economics in favor of political compromise and revenue maximization.

The Medical Era Foundation (1996-2012)

California's Compassionate Use Act of 1996 created the first state-legal medical cannabis framework, but it lacked a retail licensing structure. Dispensaries operated in legal gray areas under local ordinances until the 2003 passage of SB 420, which established voluntary ID cards but still provided no clear retail licensing pathway. Colorado's Amendment 20 in 2000 and subsequent legislation created the first true seed-to-sale regulatory model with licensed Medical Marijuana Centers beginning in 2009. By 2012, eighteen states had medical cannabis laws, but only a handful—Colorado, Michigan, Arizona, New Jersey—had functioning retail dispensary systems. Total U.S. dispensary count in 2012 was approximately 1,800 locations, concentrated heavily in California's unregulated collective model and Colorado's licensed system.

The Adult-Use Pivot (2012-2020)

Colorado and Washington voters approved adult-use legalization in November 2012, with retail sales beginning January 1, 2014 in Colorado and July 2014 in Washington. The initial years saw constrained supply and high prices—Colorado wholesale flower averaged $2,400-$2,800 per pound in 2014. Dispensary licenses were limited and valuable. Colorado capped licenses by locality, creating a scarce asset that traded hands for $250,000-$500,000 in desirable markets like Denver. Oregon's 2014 legalization and subsequent 2016 retail launch demonstrated the first oversupply warning signs. Oregon imposed no statewide cap on cultivation licenses and approved them liberally. By 2018, Oregon had over 1,000 licensed dispensaries serving a population of 4.2 million—a ratio of approximately one dispensary per 4,200 residents, far exceeding Colorado's one per 7,500. Wholesale prices collapsed to $600-$800 per pound by 2019. Dispensaries began closing in 2019-2020 as margins evaporated. California's Proposition 64 in 2016 promised the largest legal market but created a regulatory quagmire. The state required all operators to transition from the unregulated medical collective system to a dual-track licensed system by January 2018, but local jurisdictions retained veto power over retail locations. The result: thousands of cultivators licensed at the state level but only 500-600 dispensaries initially licensed locally, creating a supply bottleneck. By 2020, California had approximately 1,200 licensed dispensaries, but over 10,000 licensed cultivators. Wholesale flower prices fell from $1,400-$1,600 per pound in 2018 to $800-$1,000 by late 2020. Massachusetts, Michigan, and Illinois launched adult-use sales in 2019-2020 with tightly controlled license counts and vertical integration requirements. Initial scarcity drove premium pricing—Illinois dispensaries generated $50,000-$100,000 in daily revenue in early 2020. But each state rapidly expanded cultivation capacity while retail licensing lagged, setting up the same supply-demand imbalance.

The Pandemic Boom and Bust Cycle (2020-2023)

COVID-19 paradoxically accelerated cannabis sales as states deemed dispensaries essential businesses and consumers stockpiled products during lockdowns. U.S. legal cannabis sales grew from $13.2 billion in 2019 to $17.5 billion in 2020 and $24.6 billion in 2021, according to data from BDSA. Operators expanded rapidly, and states issued new licenses to capture tax revenue. Dispensary count nationwide grew from approximately 7,500 in January 2020 to over 12,000 by December 2022. Capital flooded the sector. Multi-state operators like Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs raised hundreds of millions through Canadian exchanges and private placements, acquiring smaller operators and building new locations. Single-state operators secured debt financing at 12-18% interest rates from specialized cannabis lenders. The assumption: federal legalization or banking reform was imminent, and scale would win. But three forces converged to end the boom. First, cultivation capacity outpaced consumption. States continued issuing cultivation licenses while demand growth slowed post-pandemic. California's wholesale flower price fell to $400-$500 per pound by mid-2022. Colorado, Oregon, and Washington saw similar declines. Second, the capital markets collapsed. The AdvisorShares Pure US Cannabis ETF (MSOS) fell from a February 2021 peak of $50.98 to under $8 by December 2022, a decline of over 84%. Cannabis SPACs that raised billions in 2020-2021 saw valuations crater. Third, federal reform stalled. The SAFE Banking Act passed the House seven times but never advanced in the Senate. The Biden administration's October 2022 announcement of a DEA review of cannabis scheduling raised hopes, but the process dragged through 2023-2024 with no resolution.

The Contraction Begins (2024-2025)

Dispensary closures accelerated through 2024. California saw approximately 400-500 licensed retail locations close between January 2024 and December 2025, reducing the total from roughly 1,400 to under 1,000. Oregon's count fell from 750 to approximately 550. Colorado experienced its first sustained decline, dropping from 1,100 to around 950 locations. Even newer markets felt pressure—Illinois closures began in late 2024 as the initial cohort of operators faced lease renewals and debt maturities with deteriorated cash flows. The closures followed predictable patterns. Small, single-location operators closed first, unable to compete on price with vertically integrated MSOs or absorb the fixed costs of compliance, security, and inventory management. Rural and secondary-market locations closed as operators consolidated into high-traffic urban cores. Operators in states with punitive tax structures—California's 15% excise tax plus local taxes reaching 10-15%—faced impossible math as wholesale costs fell but retail prices remained pressured by illicit competition. By early 2026, the contraction had become the dominant industry narrative, displacing earlier optimism about federal reform and market maturation.

Key Players in the Closure Crisis

Multi-State Operators: Consolidation and Retreat

The largest cannabis companies are closing unprofitable locations while defending core markets, prioritizing cash flow over growth. Curaleaf Holdings, the largest MSO by revenue with $1.4 billion in 2024 sales, announced in February 2026 that it would close 15-20 dispensaries across secondary markets in Arizona, Colorado, and Massachusetts while investing in high-volume Florida and New Jersey locations. Trulieve Cannabis Corp., dominant in Florida with over 180 locations, has maintained its home-state footprint but closed its five California dispensaries in late 2025, citing unsustainable unit economics. Green Thumb Industries has taken a similar approach, exiting wholesale operations in several states to focus on retail in Illinois, Pennsylvania, and New Jersey. The MSO strategy reflects a broader shift from land-grab expansion to disciplined capital allocation, but it leaves gaps in markets where they retreat.

Independent Operators: Survival Mode

Single-location and small-chain operators face existential pressure. These businesses typically lack vertical integration, forcing them to purchase wholesale products at prices that have fallen more slowly than retail prices due to retailer margin compression. They cannot access traditional bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code because cannabis remains federally illegal under 21 U.S.C. § 812, and bankruptcy courts are federal institutions. When an independent dispensary fails, it typically undergoes state receivership or informal wind-down, often leaving creditors unpaid and employees without severance. Industry associations estimate that independent operators represent 60-65% of closures in 2024-2026.

State Regulators: Navigating Contraction

State cannabis control boards face difficult choices. California's Department of Cannabis Control has attempted to slow closures by reducing licensing fees and extending renewal deadlines, but these measures address symptoms rather than root causes of oversupply and federal prohibition. Michigan's Cannabis Regulatory Agency has taken a more hands-off approach, allowing market forces to reduce dispensary count from a 2023 peak of approximately 750 to around 620 in May 2026. Massachusetts Cannabis Control Commission has maintained strict license caps, limiting closures but also constraining market evolution. No state has yet implemented a formal license buyback or market stabilization program, though California legislators discussed such proposals in early 2026.

Federal Agencies: Continued Prohibition

The Drug Enforcement Administration and Department of Justice remain the ultimate arbiters of cannabis's legal status. The DEA's ongoing review of a potential rescheduling from Schedule I to Schedule III under the Controlled Substances Act, initiated by President Biden's October 2022 directive, has proceeded through notice-and-comment rulemaking but has not concluded as of May 2026. Even if cannabis moves to Schedule III, it would remain federally prohibited for non-medical use, and the IRC Section 280E tax treatment—which disallows business expense deductions for Schedule I and II controlled substances—would likely persist, continuing to impose effective tax rates of 60-75% on dispensaries. The Federal Deposit Insurance Corporation and Federal Reserve's continued guidance discouraging banks from serving cannabis clients perpetuates the industry's cash-intensive operations and limited access to credit.

Landlords and Creditors: The Forgotten Stakeholders

Commercial property owners who leased to dispensaries face vacancy and stigma. Cannabis-specific lease rates typically ran 20-40% above comparable retail space due to perceived risk, but those premiums disappear when tenants close and landlords struggle to re-lease properties that local zoning may still restrict to cannabis use. Cannabis-focused lenders like Chicago Atlantic Real Estate Finance and AFC Gamma have seen loan defaults rise, with non-performing loans increasing from under 2% of portfolios in 2022 to 8-12% by early 2026. These lenders cannot foreclose through normal processes due to federal prohibition, creating a shadow inventory of distressed assets.

Legal and Regulatory Framework

Dispensary closures occur within a complex web of state licensing regimes, federal prohibition, tax policy, and local control that creates structural fragility.

State Licensing and Market Structure

States employ three basic licensing models, each with different implications for market stability. Limited-license states like Illinois, New York, and Ohio cap the total number of dispensary licenses, creating scarcity value but also limiting market responsiveness. When demand shifts or operators fail, replacement is slow. Open-license states like Oklahoma and Oregon issue licenses liberally to any qualified applicant, leading to rapid oversupply. Hybrid states like California and Massachusetts set no statewide caps but delegate approval to local jurisdictions, creating patchwork markets with artificial scarcity in some areas and saturation in others. Vertical integration requirements also shape closure patterns. States like New York and Pennsylvania require or strongly incentivize vertical integration, where a single entity controls cultivation, processing, and retail. This model protects operators from wholesale price volatility but requires massive capital investment. When vertically integrated operators fail, they often close entire operations rather than individual dispensaries. States allowing independent retailers create more diverse markets but expose those retailers to supply chain risk and margin compression.

Federal Prohibition and Its Consequences

Cannabis's status as a Schedule I controlled substance under 21 U.S.C. § 812 creates cascading legal barriers. Dispensaries cannot deduct ordinary business expenses under IRC Section 280E, which disallows deductions for businesses trafficking in Schedule I or II substances. A dispensary with $2 million in revenue and $1.5 million in cost of goods sold (deductible) plus $400,000 in operating expenses (non-deductible) faces federal tax on $500,000 of income rather than $100,000, creating effective tax rates of 60-75%. This tax treatment alone can render marginal operations unprofitable. Federal prohibition also blocks access to traditional banking. While the Financial Crimes Enforcement Network's 2014 guidance theoretically allows banks to serve cannabis clients, most national and regional banks decline due to risk of money laundering charges under 18 U.S.C. § 1956. Dispensaries operate largely in cash, increasing security costs, theft risk, and operational friction. The lack of banking access also prevents dispensaries from accepting credit cards, limiting transaction sizes and customer convenience. Bankruptcy protection under 11 U.S.C. is unavailable because bankruptcy courts are federal, and federal law does not recognize state-legal cannabis businesses. When a dispensary fails, it cannot reorganize under Chapter 11 or liquidate under Chapter 7. Instead, it undergoes informal wind-down or state-level receivership, often leaving creditors with pennies on the dollar.

Tax Policy Beyond 280E

State and local taxes compound federal burdens. California imposes a 15% excise tax on retail sales plus state sales tax of 7.25-10.25% depending on locality, plus local cannabis taxes reaching 10-15% in cities like Los Angeles and San Francisco. Total tax burden can reach 40% of retail price. Illinois charges a tiered excise tax based on THC content—10% on flower, 20% on edibles, 25% on concentrates—plus state and local sales taxes. These high tax rates were designed to maximize revenue during the growth phase, but they price legal cannabis above illicit alternatives during contraction, driving consumers back to unregulated sources and reducing dispensary viability.

Local Control and Zoning

Most state laws grant local governments authority to ban or restrict cannabis businesses. California's Proposition 64 explicitly preserved local control, resulting in approximately 70% of jurisdictions prohibiting retail sales. This creates dense clustering in permissive jurisdictions—Los Angeles has over 300 licensed dispensaries serving 4 million residents, while neighboring Orange County has fewer than 20 serving 3.2 million. Local zoning often requires dispensaries to locate at least 600-1,000 feet from schools, parks, and other dispensaries, limiting available real estate and driving up lease costs. When dispensaries close, these restrictions prevent adaptive reuse of the space.

State-by-State Breakdown of Closures

Closure patterns vary dramatically by state regulatory structure, market maturity, and local economic conditions.

California

California has experienced the most severe contraction in absolute numbers, with an estimated 400-500 licensed dispensaries closing between January 2024 and May 2026. The state's combination of high taxes, local bans, and massive oversupply created unsustainable conditions. Wholesale flower prices averaging $400-$500 per pound in 2026 compare to $1,400-$1,600 in 2018. Los Angeles alone saw approximately 80-100 closures, concentrated in South Los Angeles and the San Fernando Valley. The state's 15% excise tax and local taxes reaching 10-15% price legal cannabis above illicit alternatives. Governor Gavin Newsom's administration reduced cultivation license fees by 80% in 2024 and extended renewal deadlines, but these measures have not stemmed closures. Possession limits remain one ounce for flower and eight grams of concentrate for adults 21+.

Colorado

Colorado, the first state with legal adult-use sales, saw its dispensary count decline from approximately 1,100 in early 2024 to around 950 by May 2026. Closures concentrated in rural areas and secondary markets like Colorado Springs and Pueblo. Denver's market has remained relatively stable due to tourism demand. Wholesale prices fell from $1,200-$1,400 per pound in 2021 to $700-$900 in 2026. Colorado's 15% retail excise tax plus state and local sales taxes create a total burden of approximately 27-30%. The state's Marijuana Enforcement Division has not adjusted license caps or fees significantly. Possession limits are one ounce for residents, quarter-ounce for non-residents.

Oregon

Oregon's liberal licensing regime created the nation's most oversaturated market, and the contraction has been correspondingly severe. Dispensary count fell from approximately 750 in 2023 to around 550 by May 2026, a decline of nearly 27%. The Oregon Liquor and Cannabis Commission has discussed implementing license caps but has not done so. Wholesale prices remain depressed at $600-$800 per pound. The state's 17% retail tax is moderate, but oversupply drives the crisis. Rural closures have been particularly pronounced in southern Oregon, where cultivation density is highest. Possession limits are one ounce in public, eight ounces at home.

Michigan

Michigan's adult-use market launched in December 2019 and expanded rapidly through 2022, reaching approximately 750 dispensaries. By May 2026, the count had fallen to around 620, a decline of 17%. Closures concentrated in Detroit and Grand Rapids as operators consolidated. Michigan's 10% excise tax plus 6% sales tax creates a moderate burden. The state allows vertical integration but does not require it, creating a mix of business models. Wholesale prices fell from $2,000-$2,400 per pound in 2020 to $1,000-$1,200 in 2026. The Cannabis Regulatory Agency has maintained a hands-off approach. Possession limits are 2.5 ounces.

Illinois

Illinois maintained tight license controls and high barriers to entry, limiting initial closures. The state had approximately 110 dispensaries in early 2024 and around 95 by May 2026, a decline of 14%. Closures began as initial operators faced debt maturities and lease renewals with cash flows weakened by falling prices. Illinois's tiered excise tax system and high wholesale prices—$1,800-$2,200 per pound in 2026—have kept dispensaries more profitable than in other states, but the market is not immune. The state's social equity licensing program has struggled, with many equity licensees unable to secure capital to open. Possession limits are 30 grams for residents, 15 grams for non-residents.

Massachusetts

Massachusetts's Cannabis Control Commission maintained strict license caps and a slow approval process, limiting both expansion and contraction. The state had approximately 220 licensed dispensaries in early 2024 and around 200 by May 2026. Closures concentrated among social equity licensees who struggled with capitalization. The state's 10.75% excise tax plus 6.25% sales tax plus local taxes up to 3% create a total burden of approximately 20%. Wholesale prices remained relatively stable at $1,400-$1,600 per pound due to constrained supply. Possession limits are one ounce.

Oklahoma

Oklahoma's medical-only market issued licenses with minimal barriers, creating explosive growth to over 2,000 dispensaries by 2022. The subsequent contraction has been severe, with the count falling to approximately 1,200-1,300 by May 2026, a decline of 35-40%. The Oklahoma Medical Marijuana Authority has implemented modest reforms, including reducing license fees, but oversupply persists. Wholesale prices fell to $800-$1,000 per pound. The state's 7% excise tax is low, but competition drives closures. Medical possession limits are three ounces.

Arizona

Arizona's adult-use launch in January 2021 initially supported approximately 180 dispensaries, but the count fell to around 140 by May 2026. The state's dual-license system, where medical dispensaries received first priority for adult-use licenses, limited initial expansion. Closures concentrated in Phoenix and Tucson as MSOs consolidated. The state's 16% excise tax plus transaction privilege tax creates a burden of approximately 21-22%. Wholesale prices fell from $1,600-$1,800 per pound in 2021 to $1,000-$1,200 in 2026. Possession limits are one ounce.

New York

New York's adult-use market launched in December 2022 with a slow rollout focused on social equity licensees. The state had approximately 150 licensed dispensaries by early 2024 and around 130 by May 2026. Closures reflected undercapitalization of equity licensees and competition from unlicensed stores, which numbered over 1,500 in New York City alone. The Office of Cannabis Management has struggled to enforce against illicit operators. The state's 13% excise tax plus 4% sales tax is moderate. Wholesale prices remain high at $1,800-$2,200 per pound due to limited supply. Possession limits are three ounces.

Market and Business Implications

The closure wave is reshaping cannabis business models, capital allocation, and competitive dynamics in ways that will define the industry for the next decade.

MSO Consolidation and Market Power

Multi-state operators are emerging from the contraction with increased market share and pricing power. As independent operators close, MSOs absorb their customer base. In Illinois, the top four MSOs—Cresco Labs, Green Thumb Industries, Verano Holdings, and PharmaCann—now control approximately 65% of retail sales, up from 52% in 2023. This consolidation allows coordinated pricing and reduces competitive pressure. MSOs' vertical integration insulates them from wholesale price volatility, and their scale allows them to absorb fixed regulatory costs across multiple locations. The closure crisis is accelerating the industry's evolution toward oligopoly in most states.

Wholesale Price Dynamics

Wholesale cannabis prices have fallen 60-75% since 2021 peaks in most markets, but the decline is slowing as closures reduce cultivation capacity. California wholesale flower averaged $450 per pound in May 2026, down from $500 in late 2025, suggesting the market is approaching a floor. Cultivators are exiting faster than dispensaries—California's licensed cultivator count fell from over 10,000 in 2022 to approximately 6,500 by May 2026. This supply reduction should eventually stabilize prices, but the lag time creates continued pressure on retailers who purchased inventory at higher prices. Forward-looking operators are negotiating consignment arrangements with cultivators to shift inventory risk.

Capital Markets and Financing

The cannabis capital markets remain largely closed to new entrants and expansion capital. Equity financing for cannabis companies fell from $3.2 billion in 2021 to $780 million in 2024 and is tracking toward $400-500 million in 2026, according to Viridian Capital Advisors. Debt financing remains available but expensive, with senior secured notes carrying interest rates of 14-18% and warrants. Distressed debt investors are circling struggling operators, acquiring debt at discounts and positioning for control in restructurings. The closure crisis is creating opportunities for well-capitalized buyers to acquire assets at steep discounts—dispensary licenses that traded for $500,000-$1 million in 2021 are selling for $100,000-$200,000 in 2026 in states like Colorado and Oregon.

Real Estate and Lease Dynamics

Cannabis-specific real estate is repricing downward. Lease rates that reached $60-$80 per square foot in prime California locations in 2021 have fallen to $35-$50 in 2026. Landlords are offering tenant improvement allowances and rent abatement to attract cannabis tenants, reversing the premium pricing of the boom years. But many properties remain vacant because local zoning restricts them to cannabis use and the pool of viable operators has shrunk. Some jurisdictions are considering zoning amendments to allow adaptive reuse, but progress is slow. The overhang of vacant cannabis-zoned real estate will take years to clear.

Employment and Labor Markets

Dispensary closures have eliminated tens of thousands of retail jobs, but the impact varies by role. Budtenders and entry-level retail staff face the most displacement, with limited transferability of skills. Management and compliance roles have better prospects, as surviving operators need experienced personnel. Wages for budtenders have fallen from $16-$20 per hour in 2021-2022 to $14-$17 in 2026 in most markets, reflecting oversupply of labor. Unionization efforts, which gained momentum in 2022-2023, have stalled as operators resist labor cost increases during the contraction. The United Food and Commercial Workers union represents approximately 10,000 cannabis workers nationwide, down from 15,000 in 2023.

Ancillary Services Contraction

Businesses serving the cannabis industry—software providers, testing labs, security companies, packaging suppliers—are experiencing their own contraction. Point-of-sale software providers like Dutchie and Treez have laid off staff and consolidated as dispensary clients close. Testing labs in California and Oregon have closed as sample volumes decline. Security companies are competing aggressively on price. The ancillary sector's struggles receive less attention than dispensary closures but represent significant economic impact.

What Experts Say

Industry analysts, operators, and policymakers offer divergent views on the causes and solutions for the closure crisis, but most agree the contraction will continue through 2027. Beau Whitney, senior economist at Whitney Economics, a cannabis-focused consulting firm, said in an April 2026 interview that the closure wave represents a necessary market correction after years of irrational expansion. According to Whitney, states issued licenses based on political pressure to maximize tax revenue rather than sustainable market sizing, creating structural oversupply that no amount of demand growth could absorb. Whitney projects that U.S. dispensary count will fall from approximately 11,000 in early 2024 to 7,500-8,000 by end of 2027 before stabilizing. Emily Paxhia, co-founder of Poseidon Investment Management, a cannabis-focused investment firm, said in a March 2026 investor letter that the closure crisis is separating well-capitalized, operationally excellent businesses from undercapitalized operators who relied on continued access to growth capital. According to Paxhia, the surviving operators will emerge with stronger market positions and the industry will be healthier for the consolidation, though the transition is painful. Aaron Smith, co-founder of the National Cannabis Industry Association, said in testimony before the California State Assembly in February 2026 that state and federal policy failures are driving closures of compliant operators while the illicit market thrives. According to Smith, California's tax burden and federal prohibition under 21 U.S.C. § 812 create impossible economics for legal businesses. Smith advocates for eliminating the state excise tax, reducing local taxes, and federal rescheduling to Schedule III to eliminate IRC Section 280E. Hilary Bricken, attorney at Harris Bricken and cannabis law specialist, said in a May 2026 blog post that the lack of bankruptcy protection under 11 U.S.C. is creating chaotic wind-downs where employees and small creditors get nothing while secured lenders seize assets. According to Bricken, states should create specialized receivership processes for cannabis businesses to ensure orderly dissolution and fair treatment of creditors. Dr. Beau Kilmer, co-director of the RAND Drug Policy Research Center, said in an April 2026 research briefing that the closure crisis demonstrates the limits of state-by-state legalization without federal coordination. According to Kilmer, the lack of interstate commerce keeps markets fragmented and prevents efficient capital allocation, while federal prohibition prevents normal business operations. Kilmer's research suggests that even full federal legalization would not immediately solve oversupply in states like California and Oregon, where cultivation capacity far exceeds local demand and export remains illegal.

What's Next: Scenarios and Decision Points

The dispensary closure trend will likely continue through 2027, with the pace and severity depending on federal policy decisions, state regulatory responses, and macroeconomic conditions. The most significant near-term decision point is the DEA's final rule on cannabis rescheduling. The agency published a Notice of Proposed Rulemaking in August 2023 proposing to move cannabis from Schedule I to Schedule III under the Controlled Substances Act. The comment period closed in December 2023, and the DEA held administrative law judge hearings in late 2024 and early 2025. A final rule is expected in late 2026 or early 2027. If cannabis moves to Schedule III, it would remain federally illegal for non-medical use, but IRC Section 280E would no longer apply, allowing dispensaries to deduct ordinary business expenses. This change could improve dispensary profitability by 15-25 percentage points, potentially slowing closures. However, Schedule III would also subject cannabis to FDA regulation, creating new compliance costs and uncertainty. State-level policy responses will shape regional outcomes. California legislators are considering a bill to eliminate the state's 15% excise tax and replace it with a lower weight-based cultivation tax, which would reduce retail prices and improve dispensary margins. The bill faces opposition from local governments that rely on cannabis tax revenue. If enacted in late 2026, it could slow California closures in 2027. Michigan and Illinois are considering similar tax reductions. Oregon is debating whether to implement license caps to prevent future oversupply, but such caps would not address existing excess capacity. Banking reform remains a possibility, though prospects are uncertain. The SAFE Banking Act, which would protect banks serving state-legal cannabis businesses from federal penalties, has passed the House seven times but stalled in the Senate. If Republicans control the Senate after the 2026 midterm elections, some analysts believe SAFE could advance as a standalone bill, though others expect it to remain tied to broader cannabis reform that lacks consensus. Banking access would reduce dispensary operating costs and improve access to credit, potentially helping marginal operators survive. Macroeconomic conditions will influence the pace of closures. If the U.S. enters recession in late 2026 or 2027, consumer discretionary spending on cannabis will decline, accelerating closures. Conversely, continued economic growth could stabilize demand and slow the contraction. Interest rates also matter—if the Federal Reserve cuts rates significantly, refinancing opportunities could help indebted operators extend maturities and avoid closure. The illicit market's trajectory is another variable. If states fail to enforce against unlicensed operators, legal dispensaries will continue losing market share and closing. New York's struggle to close over 1,500 unlicensed stores in New York City illustrates the challenge. California has increased enforcement funding, but results remain limited. Effective illicit market suppression could redirect consumers to legal channels and improve dispensary viability